COMPASS Pathways plc

NasdaqGS CMPS

COMPASS Pathways plc Gross Profit Margin for the year ending December 31, 2023

COMPASS Pathways plc Gross Profit Margin is NA for the year ending December 31, 2023. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

NasdaqGS: CMPS

COMPASS Pathways plc

CEO	Mr. Kabir Kumar Nath M.A., M.B.A.
IPO Date	Sept. 18, 2020
Location	United Kingdom
Headquarters	33 Broadwick Street
Employees	186
Sector	Health Care
Industries Pharmaceuticals Mental Health

Description

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Key trends

Past 5 years